Cargando…
Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
BACKGROUND: Early initiation of enzyme replacement therapy (ERT) with recombinant human acid alpha-glucosidase is an effective treatment for patients with infantile-onset Pompe disease (IOPD) but cannot prevent a slow progression of myopathy. Albuterol has been shown to be helpful in adult patients...
Autores principales: | Chien, Yin-Hsiu, Hwu, Wuh-Liang, Lee, Ni-Chung, Tsai, Fuu-Jen, Koeberl, Dwight D., Tsai, Wen-Hui, Chiu, Pao-Chin, Chang, Chaw-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406275/ https://www.ncbi.nlm.nih.gov/pubmed/28480166 http://dx.doi.org/10.1016/j.ymgmr.2017.04.004 |
Ejemplares similares
-
Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
por: Chien, Yin-Hsiu, et al.
Publicado: (2020) -
Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study
por: Peng, Steven Shinn-Forng, et al.
Publicado: (2016) -
The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
por: Chiang, Shu-Chuan, et al.
Publicado: (2020) -
Development of Newborn Screening for Pompe Disease
por: Hwu, Wuh-Liang, et al.
Publicado: (2020) -
A review of treatment of Pompe disease in infants
por: Chien, Yin-Hsiu, et al.
Publicado: (2007)